For this article, Nadia S. Halim interviewed Ronald Evans, professor in the gene expression laboratory, Salk Institute, La Jolla, Calif., and Hongwu Chen, postdoctoral fellow, Salk Institute. Both are ...
Figure 1: Nuclear receptor co-regulators modulate the transcriptional ... an alternative model of hormone-independent tumor progression invests ER AF-1 with increased functional significance.
Therefore, whereas the pre-ovulatory surge of luteinizing hormone induces both ovulation and luteinization, the ability to suppress the action of nuclear receptors is essential for the coordinated ...
PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...
About two-thirds of people with breast cancer have a kind known as hormone receptor positive. Hormones are chemical substances that circulate in the bloodstream and help control most of our bodies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback